Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...